• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:一名年轻女性长期使用地诺孕素期间卵巢子宫内膜异位囊肿发生恶性转化。

Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady.

作者信息

Chang Yi-Ting, Lu Ting-Fang, Sun Lou, Shih Yu-Hsiang, Hsu Shih-Tien, Liu Chin-Ku, Hwang Sheau-Feng, Lu Chien-Hsing

机构信息

Department of Gynecology and Obstetrics, Taichung Veterans General Hospital, Taichung, Taiwan.

Department of Food and Nutrition, Providence University, Taichung, Taiwan.

出版信息

Front Oncol. 2024 Jan 31;14:1338472. doi: 10.3389/fonc.2024.1338472. eCollection 2024.

DOI:10.3389/fonc.2024.1338472
PMID:38357201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10864460/
Abstract

Endometriosis is a benign disease, which is also regarded as a precursor to ovarian malignancy. Dienogest is a progestin treatment for endometriosis with efficacy and tolerability. A 35-year-old Taiwanese lady with ovarian endometrioma had taken dienogest for the last 5 years. During sonographic follow-up, surgery was suggested owing to suspicious of malignant transformation of ovarian endometrioma. While she hesitated and turned to receive two cycles of oocyte retrieval because of nulliparity. Meanwhile, more papillary growth in the ovarian endometrioma with intratumor flow was found during follow-up. Laparoscopic enucleation was performed later, and pathology revealed clear cell carcinoma with peritoneal involvement, at least FIGO stage IIB. She then underwent debulking surgery to grossly no residual tumor and received adjuvant chemotherapy with no tumor recurrence in post-operative 17-months follow-up. Considering fertility preservation, conservative treatment of ovarian endometrioma is typically indicated for those women who have not yet completed childbearing. However, malignant transformation may still occur despite long-term progestin treatment. Therefore, careful image follow-up is still indispensable.

摘要

子宫内膜异位症是一种良性疾病,也被视为卵巢恶性肿瘤的前驱病变。地诺孕素是一种用于治疗子宫内膜异位症的孕激素,具有疗效和耐受性。一名35岁患有卵巢子宫内膜异位囊肿的台湾女性在过去5年一直服用地诺孕素。在超声随访期间,由于怀疑卵巢子宫内膜异位囊肿发生恶变,建议进行手术。然而,由于未生育,她犹豫不决,转而接受了两个周期的取卵。同时,随访期间发现卵巢子宫内膜异位囊肿内出现更多乳头样生长且有瘤内血流信号。随后进行了腹腔镜剥除术,病理显示为透明细胞癌伴腹膜受累,至少为国际妇产科联盟(FIGO)IIB期。她随后接受了肿瘤减灭术,术后大体无残留肿瘤,并接受了辅助化疗,术后17个月随访无肿瘤复发。考虑到保留生育功能,对于尚未完成生育的女性,卵巢子宫内膜异位囊肿通常采用保守治疗。然而,尽管长期使用孕激素治疗,仍可能发生恶变。因此,仔细的影像随访仍然不可或缺。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc0d/10864460/fd4e994e5831/fonc-14-1338472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc0d/10864460/fd4e994e5831/fonc-14-1338472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc0d/10864460/fd4e994e5831/fonc-14-1338472-g001.jpg

相似文献

1
Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady.病例报告:一名年轻女性长期使用地诺孕素期间卵巢子宫内膜异位囊肿发生恶性转化。
Front Oncol. 2024 Jan 31;14:1338472. doi: 10.3389/fonc.2024.1338472. eCollection 2024.
2
Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma.卵巢子宫内膜异位囊肿术后长期使用地诺孕素的临床经验
Obstet Gynecol Sci. 2018 Jan;61(1):111-117. doi: 10.5468/ogs.2018.61.1.111. Epub 2017 Dec 18.
3
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms.地诺孕素可减少内异症囊肿体积和内异症相关疼痛症状。
J Obstet Gynaecol. 2021 Nov;41(8):1246-1251. doi: 10.1080/01443615.2020.1867962. Epub 2021 Feb 25.
4
Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.术后药物预防内异症复发的疗效:促性腺激素释放激素(GnRH)激动剂后周期性口服避孕药(OC)与地诺孕素的比较。
J Korean Med Sci. 2022 Jul 4;37(26):e207. doi: 10.3346/jkms.2022.37.e207.
5
Malignant Transformation of an Ovarian Endometrioma during Endometriosis Treatment: A Case Report.子宫内膜异位症治疗期间卵巢子宫内膜瘤的恶性转化:一例报告
Case Rep Obstet Gynecol. 2018 Sep 4;2018:6210172. doi: 10.1155/2018/6210172. eCollection 2018.
6
Women's fertility after laparoscopic cystectomy of endometrioma and other benign ovarian tumors - a 24-month follow-up retrospective study.子宫内膜异位囊肿及其他良性卵巢肿瘤腹腔镜囊肿切除术后的女性生育能力——一项为期24个月的随访回顾性研究。
Neuro Endocrinol Lett. 2016 Sep;37(4):295-300.
7
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.地诺孕素治疗期间卵巢子宫内膜异位囊肿恶变的显著危险因素:一例病例报告及回顾性研究
J Med Case Rep. 2019 Oct 22;13(1):314. doi: 10.1186/s13256-019-2236-z.
8
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.地诺孕素长期用于卵巢子宫内膜异位症女性的疗效与安全性
Reprod Sci. 2018 Mar;25(3):341-346. doi: 10.1177/1933719117725820. Epub 2017 Nov 21.
9
Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.卵母细胞冷冻保存用于卵巢子宫内膜异位症女性的生育力保存。
Reprod Biomed Online. 2020 Jun;40(6):827-834. doi: 10.1016/j.rbmo.2020.01.028. Epub 2020 Feb 5.
10
Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months.地诺孕素治疗子宫内膜异位症患者的疗效与安全性:一项为期12个月的单中心观察性研究。
Clin Exp Reprod Med. 2016 Dec;43(4):215-220. doi: 10.5653/cerm.2016.43.4.215. Epub 2016 Dec 26.

本文引用的文献

1
Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019.韩国子宫内膜异位症的现行治疗方法:2010 年至 2019 年全国范围内数据的分析。
Sci Rep. 2023 Jun 13;13(1):9573. doi: 10.1038/s41598-023-36291-1.
2
Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review).子宫内膜异位症恶变的临床病理特征、分子特征及新型诊断策略(综述)
Exp Ther Med. 2023 Apr 24;25(6):279. doi: 10.3892/etm.2023.11978. eCollection 2023 Jun.
3
A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
子宫内膜异位症和卵巢癌组织类型之间遗传关系的多层次研究。
Cell Rep Med. 2022 Mar 15;3(3):100542. doi: 10.1016/j.xcrm.2022.100542.
4
ESHRE guideline: endometriosis.ESHRE 指南:子宫内膜异位症。
Hum Reprod Open. 2022 Feb 26;2022(2):hoac009. doi: 10.1093/hropen/hoac009. eCollection 2022.
5
Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?子宫内膜异位症相关的卵巢透明细胞癌:一种特殊的实体?
J Cancer. 2021 Sep 23;12(22):6773-6786. doi: 10.7150/jca.61107. eCollection 2021.
6
Endometriosis-associated cancer.子宫内膜异位症相关癌症。
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
7
Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes.卵巢透明细胞癌:流行病学、病理和生物学特征、治疗选择和临床结局。
Gynecol Oncol. 2021 Sep;162(3):741-750. doi: 10.1016/j.ygyno.2021.06.033. Epub 2021 Jul 8.
8
The relation between endometrioma and ovarian cancer.子宫内膜异位囊肿与卵巢癌之间的关系。
Minerva Obstet Gynecol. 2021 Jun;73(3):347-353. doi: 10.23736/S2724-606X.21.04757-2.
9
Endometriosis is a chronic systemic disease: clinical challenges and novel innovations.子宫内膜异位症是一种慢性全身性疾病:临床挑战与新的创新。
Lancet. 2021 Feb 27;397(10276):839-852. doi: 10.1016/S0140-6736(21)00389-5.
10
Endometriosis.子宫内膜异位症
N Engl J Med. 2020 Mar 26;382(13):1244-1256. doi: 10.1056/NEJMra1810764.